Showing results (21-30 of 244) with videos related to
Sort By:
Pageof 25
Biochemical Pharmacology|June 1, 1991
Structure-activity relationship of ligands of human plasma adenosine deaminase2J G Niedzwicki, D R AbernethyClinical Pharmacokinetics|March 1, 1982
Pharmacokinetics of drugs in obesityD R Abernethy, D J GreenblattBiochemical and Biophysical Research Communications|March 16, 1992
Verapamil blocks basal and angiotensin II-induced RNA synthesis of rat aortic vascular smooth muscle cellsN S Andrawis, D R AbernethyThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker ratsE L Todd, D R AbernethyClinical Pharmacology and Therapeutics|June 1, 1989
Calcium antagonists in geriatric patients: diltiazem in elderly persons with hypertensionS C Montamat, D R AbernethyThe American Journal of Cardiology|December 14, 1987
Acute and chronic studies of diltiazem in elderly versus young hypertensive patientsD R Abernethy, S C MontamatGeriatrics|August 1, 1987
Cardiac drugs: adjusting their use in aging patientsJ B Schwartz, D R AbernethyBritish Journal of Clinical Pharmacology|August 1, 1987
N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensivesS C Montamat, D R AbernethyThe American Journal of Cardiology|April 1, 1984
Lidocaine disposition in obesityD R Abernethy, D J GreenblattJournal of Cardiovascular Pharmacology|February 1, 1988
Verapamil pharmacodynamics and disposition in obese hypertensive patientsD R Abernethy, J B SchwartzPageof 25